Model
Edge
CollPlant Biotechnologies Ltd
CLGN
Filing Type
20-F
Filing Date
3/31/2020
Updated
4/1/20, 1:57 AM
Copy Ref
Filing
20-F
Earnings Release
Exhibits
20-F
Annual and Transition Report of Foreign Private Issuers
EX-2.1
DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12
EX-4.24
FORM OF CONVERTIBLE LOAN AGREEMENT BETWEEN THE COMPANY AND AMY SAGY
EX-4.25
FORM OF CONVERTIBLE LOAN AGREEMENT BETWEEN THE COMPANY AND U.S. INVESTORS
EX-4.26
FORM OF PRICE PROTECTION AGREEMENT BETWEEN THE COMPANY AND AMY SAGY
EX-4.27
FORM OF PRICE PROTECTION AGREEMENT BETWEEN THE COMPANY AND U.S. INVESTORS
EX-4.28
FORM OF REGISTRATION RIGHTS AGREEMENT
EX-4.29
FORM OF WARRANT ISSUED BY THE COMPANY TO AMY SAGY AND U.S. INVESTORS PURSUANT TO THE CONVERTIBLE LOAN AGREEMENT
EX-4.30
FORM OF SECURITIES PURCHASE AGREEMENT DATED AS OF FEBRUARY 13, 2020 BY AND BETWEEN THE COMPANY AND THE PURCHASERS NAMED THEREIN
EX-12.1
CERTIFICATION
EX-12.2
CERTIFICATION
EX-13.1
CERTIFICATION
EX-13.2
CERTIFICATION
EX-15.1
CONSENT OF KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
EX-101.INS
XBRL INSTANCE FILE